Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Similar documents
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Unprotected LM intervention

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

LM stenting - Cypher

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

Declaration of conflict of interest NONE

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

PCI for Left Anterior Descending Artery Ostial Stenosis

Ted Feldman, M.D., MSCAI FACC FESC

Ischemic Heart Disease Interventional Treatment

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

Surgery Grand Rounds

EACTS Adult Cardiac Database

Multivessel Coronary Artery Disease : CABG. Zürich, F. Siclari MD

Ischemic Heart Disease Interventional Treatment

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

Lessons learned From The National PCI Registry

PCI for Renal Artery stenosis

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Supplementary Online Content

Most Patients with Elective Left Main Disease. Farrel Hellig

CABG alone. It s enough? / Μόνο η αορτοστεφανιαία παράκαμψη είναι αρκετή;

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Who is the high risk patient?

Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial

THE NATIONAL QUALITY FORUM

Prevention of Coronary Stent Thrombosis and Restenosis

How to Perform Hybrid Myocardial Revascularisation: Interventional Perspective

High Risk PCI for Heart Failure

Percutaneous Intervention of Unprotected Left Main Disease

The MAIN-COMPARE Study

Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut

The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

DECLARATION OF CONFLICT OF INTEREST

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

The Second Best Arterial Graft:

Management of Cardiogenic shock. Prof. Christian JM Vrints

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan

Adults With Diagnosed Diabetes

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

MICS CABG. Putting the future of MICS in your hands today

Controversies in Cardiac Surgery

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

SUPPLEMENTAL MATERIAL

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Southern Thoracic Surgical Association CABG in 2012: Implications of the New ESC/EACTS Guidelines

Emergency surgery in acute coronary syndrome

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

8. Nov, 2018 Athens Clossroad 2018, Athens GREEK

Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Setting The setting was a hospital. The economic study was carried out in Australia.

Coronary Artery Bypass Grafting For Acute Myocardial Infarction in Stent ERA

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore

Left Main and Bifurcation Summit I. Lessons from European LM Studies

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

About OMICS International Conferences

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Better CABGs vs Better PCI Devices

Left Main PCI vs. CABG: Real World

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

PCI vs. CABG From BARI to Syntax, Is The Game Over?

PCI for Chronic Total Occlusions

Prevention and Management of Cardiac Adverse Event

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

In-Ho Chae. Seoul National University College of Medicine

Cardiogenic Shock. Carlos Cafri,, MD

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

CPORT E Trial. Atlantic C PORT

TAVR y Enfermedad Coronaria. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Associate Professor of Medicine

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

What do the guidelines say?

Percutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk

Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era

Management of High-Risk Coronary Artery Disease

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

Masashi Kimura, MD Etsuo Tsuchikane, MD Osamu Katoh, MD Toyohashi Heart Center, Japan

Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Contrast Induced Nephropathy

Transcription:

CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of Medicine

Randomized Trials (PCI vs CABG) PCI CABG Mortality Cardiac Events Long-Term Survival

PCI for Unprotected LMT disease O Keefe JH et al. Am J Cardiol 1989;64:144-147 Technical feasibility 3-year mortality: 64% Ellis SG et al. Circulation 1997;96:3867-3872 Initial report from the ULTIMA registry (n=107) 6-months mortality: 10.6% Park S-J et al. J Am Coll Cardiol 1998;31:37-42 42 patients with normal LV In-hospital mortality: 0% Restenosis (unstable AP): 17% within 2 months Tan WA et al. Circulation 2001;104:1609 ULTIMA registry (n=279) Hospital mortality: 13.7%, 1-year mortality: 24.2% For low risk group (32%) In-hospital mortality: 0%, 1-year mortality: 3.4%

CABG for patients with LMT disease Ellis SG et al. Am Heart J 1998;135:335-338 In-hospital mortality: 2.3% 3-year mortality: 15.6% STS National Database 1997 In-hospital mortality: 2.8% Annual Report 2003 from JACAS In-hospital mortality (elective): 1.12% (LMT only) 0.91% (LMT + 1VD) 1.68% (LMT + 2VD) 1.68% (LMT + 3VD)

Recent Evolution of Techniques and Devices PCI Rotational Coronary Atherectomy Directional Coronary Atherectomy New Stents (Drug Eluting Stents) GP IIb/IIIa receptor blockers PCPS CABG Aggressive use of arterial conduits Off-Pump CABG techniques

Coronary bypass surgery with internal-thoracic-artery grafts -Effects on survival over a 15-year-period Cameron A et al. N Engl J Med 1996;334:216-219

Effect of arterial revascularization on survival: a systematic review of studies comparing bilateral and single internal mammary arteries Taggart DP. Lancet 2001;358:870-875

Improved survival with multiple left-sided bilateral internal thoracic artery grafts Schmidt SE. Ann Thorac Surg 1997;64:9-15

Off-Pump CABG (Personal Experience, HY) Kyoto Prefectural University of Medicine (Kyoto) 310 cases Takahashi Hospital (Kobe) 129 cases Kyoto Miniren Chuo Hospital (Kyoto) 47 cases Saiseikai Suita Hospital (Osaka) 13 cases Makiminato Central Hospital (Okinawa) 10 cases Uemura Hospital (Kagoshima) 5 cases Marutamachi Hospital (Kyoto) 4 cases Kumamoto Red Cross Hospital (Kumamoto) 2 cases Total 520 cases

% of Off-Pump CABG in Isolated CABG (Kyoto Prefectural University of Medicine) (%) 59 70 97 80 19

Questions - Less Invasive? Operative Mortality & Morbidity - Quality of Grafting? Graft Patency Long-term Results

Subjects (Kyoto Prefectural University of Medicine) Off-Pump CABG (1997.3-2003.6) Consecutive 311 cases (including MIDCAB) On-Pump CABG (1998.1-2003.6) Consecutive 198 cases (isolated CABG) Aortic Cross Clamp 127 cases 71 cases

Patients Characteristics Off-Pump CABG On-Pump CABG (n = 311) (n = 198) p value Age (years) 68 10 65 9 < 0.001 Sex (M:F) 235 : 76 142 : 56 NS Cerebrovasc Dis 177 (56%) 60 (30%) < 0.001 > > moderate risk) Renal Dysfunction 33 (11%) 7 (4%) < 0.05 Cr > 1.5 mg/dl) DM 139 (44%) 78 (39%) NS Emergent/Urgent 136 (43%) 71 (36%) NS No. of Cor Dis 2.3 0.7 2.5 0.7 NS LMT Lesion 112 (36%) 67 (34%) NS LVEF (%) 61 15 57 15 < 0.05 Pre Op IABP 14 (5%) 14 (7%) NS

Early Results Off-Pump CABG On-Pump CABG (n = 311) (n = 198) p value LOS 17 (5%) 9 (5%) NS PMI 14 (4%) 11 (6%) NS CKMB max (IU/dl) 27 44 49 71 < 0.001 Circ Support 5 (2%) 8 (4%) NS Af 80 (25%) 23 (11%) NS Renal Dysfunction 53 (17%) 20 (10%) NS Cr max (mg/dl) 1.35 1.15 1.4 1.1 NS Prolonged Ventilation 12 (4%) 16 (11%) < 0.01 Mediastinitis 0 (0%) 0 (0%) NS CRP max (mg/dl) 20 7 19 6 NS Stroke Intraop 0 (0%) 4 (2%) < 0.05 Postop 3 (1%) 2 (1%) NS TIA 2 (0.6%) 3 (2%) NS Mortality 1 (0.3%) 1 (0.5%) NS

(rate) 1.1 0.9 0.7 0.5 0.3 0.1 Survival On:89% Off:79% NS 0 10 20 30 40 50 60 70 80 (Months) (Months)

(rate) 1.1 0.9 0.7 0.5 0.3 0.1 Freedom from Cardiac Death On:94% Off:88% 0 10 20 30 40 50 60 70 80 NS (Months)

(rate) 1.1 0.9 0.7 0.5 0.3 0.1 Freedom from Cardiac Events On:81% Off:65% 0 10 20 30 40 50 60 70 80 NS (Months)

(rate) 1.1 0.9 0.7 0.5 0.3 0.1 Freedom from PCI On:90% Off:88% 0 10 20 30 40 50 60 70 80 NS (Months)

Clinical Risk Factors Affecting In-Hospital Adverse Events Outcomes (PCI) Advanced age Female gender Diabetes Prior MI Multivessel disease Left main or equivalent coronary disease A large area of myocardium at risk Pre-existing impairment of LV or renal function Collateral vessels supplying significant areas of myocardium that originate distal to the segment to be dilated

Risk Factors Affecting Hospital Outcomes (CABG) Urgency of operation Advanced age 1 or more prior coronary bypass surgery Left ventricular EF < 40% Female sex Peripheral vascular disease Dialysis or creatinine > 2 mg/dl COPD Irrespective to Lesion site or Lesion Morphology

Patients Characteristics (Off-Pump CABG) LMT Lesion (+) LMT Lesion (-) (n = 113) (n = 186) p value Age (years) 69 10 67 9 NS Sex (M:F) 90 : 22 138 : 48 NS Cerebrovasc Dis 69 (62%) 101 (54%) NS > moderate risk) Renal Dysfunction 10 (9%) 21 (11%) NS Cr > 1.5 mg/dl) DM 48 (43%) 84 (45%) NS Emergent/Urgent 71 (64%) 61 (33%) < 0.001 No. of Cor Dis 0.05 2.5 0.6 2.3 0.8 < LVEF (%) 63 15 61 15 NS Pre Op IABP 8 (7%) 6 (3%) NS

Early Results (Off-Pump CABG) LMT Lesion (+) LMT Lesion (-) (n = 113) (n = 186) p value LOS 9 (8%) 9 (5%) NS PMI 9 (8%) 5 (3%) < 0.05 CKMB max (IU/dl) 36 57 21 35 < 0.001 Af 32 (29%) 49 (26%) NS Renal Dysfunction 25 (22%) 28 (15%) NS Ventilation Time (hours) 14 39 10 26 NS ICU Stay (days) 2.8 2.5 2.7 2.5 NS Mediastinitis 0 (0%) 0 (0%) NS CRP max (mg/dl) 21 7 20 7 NS Stroke Intraop 0 (0%) 0 (0%) NS Postop 2 (3%) 1 (0.5%) NS TIA 0 (0%) 3 (1.5%) NS Mortality 1 (0.9%) (pre op AMI) 0 (0%) NS

Survival (Off-Pump CABG) (rate) 1 LMT(-) :83% ns 0.5 LMT(+) :73% 0 5 0 (Months)

(rate) 1 0.5 Freedom from Cardiac Death (Off-Pump CABG) LMT(+) :91% LMT(-) :87% ns 0 5 0 (Months)

(rate) 1 Freedom from Cardiac Events (Off-Pump CABG) LMT(+) :82% ns 0.5 LMT(-) :63% 0 5 0 (Months)

(rate) 1 Freedom from PCI (Off-Pump CABG) LMT(+) :94% ns 0.5 LMT(-) :84% 0 5 0 (Months)

Patients Characteristics (Off-Pump CABG, LMT Lesion (+)) Age > 70 years Age < 70 years (n = 61) (n = 52) p value Age (years) 76 4 62 6 < 0.001 Sex (M:F) 45 : 16 46 : 6 < 0.05 Cerebrovasc Dis 42 (69%) 27 (52%) NS > moderate risk) Renal Dysfunction 5 (8%) 5 (10%) NS Cr > 1.5 mg/dl) DM 29 (48%) 19 (37%) NS Emergent/Urgent 49 (80%) 22 (42%) < 0.001 No. of Cor Dis 2.5 0.6 2.4 0.6 NS LVEF (%) 64 17 61 13 NS Pre Op IABP 4 (7%) 4 (8%) NS

Early Results (Off-Pump CABG, LMT Lesion (+)) Age > 70 years Age <70 years (n = 61) (n = 52) p value LOS 4 (7%) 5 (10%) NS PMI 3 (5%) 6 (12%) NS CKMB max (IU/dl) 31 45 42 69 NS Af 19 (31%) 13 (25%) NS Renal Dysfunction 18 (30%) 7 (13%) < 0.05 Ventilation Time (hours) 14 46 11 29 NS ICU Stay (days) 3.2 2.8 2.5 2.2 NS Mediastinitis 0 (0%) 0 (0%) NS CRP max (mg/dl) 21 7 20 8 NS Stroke Intraop 0 (0%) 0 (0%) NS Postop 2 (3%) 0 (0%) NS TIA 0 (0%) 0 (0%) NS Mortality 1 (1.6%) (pre op AMI) 0 (0%) NS

Survival (Off-Pump CABG, LMT Lesion (+)) (rate) 1 Under 70 :91% ns 0.5 Over 70 :67% 0 5 0 (Months)

Freedom from Cardiac Death (Off Pump CABG, LMT Lesion(+)) (rate) 1 0. 5 Under 70 :100% Over 70 :86% ns 0 5 0 (Months)

Freedom from Cardiac Events (Off Pump CABG, LMT Lesion(+)) (rate) 1 0. 5 Under 70 :98% p < 0.05 Over 70 :74% 0 5 0 (Months)

Freedom from PCI (Off-Pump CABG, LMT Lesion (+)) (rate) 1 0. 5 Under 70 :98% Over 70 :91% ns 0 5 0 (Months)

Summary - The operative mortality, 1-year mortality, and 5-year mortality of Off-Pump CABG for patients with LMT disease were 0.9%, 3.5%, and 27%, respectively. - The operative mortality, 1-year mortality, and 5-year mortality of Off-Pump CABG for elderly patients with LMT disease were 1.8%, 4.9%, and 33%, respectively. - The operative mortality of Off-Pump CABG for patients with/without LMT disease without AMI was actually zero.

Conclusions - CABG can be performed even for elderly patients with LMT disease with reasonably low mortality and morbidity and good long-term results. - CABG is a choice of care even for elderly patients with LMT disease as long as the patients is in a stable hemodynamic condition.